title: Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients.
abstract: A new paradigm has emerged relating the pathogenesis of rheumatoid arthritis (RA), focused on the balance between T helper type 17 cells and regulatory T cells (T(regs) ). In humans, both subpopulations depend on transforming growth factor (TGF)-β for their induction, but in the presence of inflammatory cytokines, such as interleukin (IL)-6, the generation of Th17 is favoured. Tocilizumab is a therapeutic antibody targeting the IL-6 receptor (IL-6R), which has demonstrated encouraging results in RA. The aim of this study was to evaluate the effect of tocilizumab on Th1 cells, Th17 cells, IL-17 and interferon (IFN)-γ double secretors Th17/Th1 cells, and T(regs)  in RA patients. Eight RA patients received tocilizumab monthly for 24 weeks and blood samples were obtained every 8 weeks to study T cell populations by flow cytometry. The frequency of Th17 cells, Th1 cells and Th17/Th1 cells was evaluated in peripheral blood mononuclear cells (PBMCs) activated in vitro with a polyclonal stimulus. T(regs)  were identified by their expression of forkhead box protein 3 (FoxP3) and CD25 by direct staining of PBMCs. Although no changes were detected in the frequency of Th1 or Th17 cells, the percentages of peripheral T(regs)  increased after therapy. In addition, the infrequent Th17/Th1 subpopulation showed a significant increment in tocilizumab-treated patients. In conclusion, tocilizumab was able to skew the balance between Th17 cells and T(regs)  towards a more protective status, which may contribute to the clinical improvement observed in RA patients.
authors: Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Universidad de Chile/Millennium Institute on Immunology and Immunotherapy-Chile, Santiago, Chile.
authors: B
authors: B
authors: Pesce
authors: L
authors: L
authors: Soto
authors: F
authors: F
authors: Sabugo
authors: P
authors: P
authors: Wurmann
authors: M
authors: M
authors: Cuchacovich
authors: M N
authors: MN
authors: López
authors: P H
authors: PH
authors: Sotelo
authors: M C
authors: MC
authors: Molina
authors: J C
authors: JC
authors: Aguillón
authors: D
authors: D
authors: Catalán
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D058504:Th17 Cells / Q000187:drug effects* / Q000276:immunology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; C502936:tocilizumab
references: Arthritis Rheum. 2008 Mar;58(3):754-63
references: 18311788
references: Nat Med. 2010 Feb;16(2):191-7
references: 20062065
references: J Immunol. 2010 Feb 15;184(4):2130-9
references: 20083667
references: Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14751-6
references: 20679229
references: Rheumatology (Oxford). 2009 Jun;48(6):602-6
references: 19269955
references: Rheumatology (Oxford). 2006 Oct;45(10):1210-7
references: 16571607
references: Rheumatology (Oxford). 2011 Oct;50(10):1908-15
references: 21752873
references: Nat Immunol. 2008 Jun;9(6):641-9
references: 18454151
references: Arthritis Rheum. 2012 Aug;64(8):2499-503
references: 22488116
references: J Rheumatol. 2009 Nov;36(11):2397-402
references: 19797510
references: Arthritis Rheum. 2008 Dec;58(12):3710-9
references: 19035481
references: J Rheumatol. 2007 May;34(5):1184-7
references: 17477484
references: Nat Clin Pract Rheumatol. 2006 Nov;2(11):619-26
references: 17075601
references: Nature. 2006 May 11;441(7090):235-8
references: 16648838
references: Arthritis Rheum. 2009 Jun;60(6):1647-56
references: 19479869
references: Ann Rheum Dis. 1993 Mar;52(3):232-4
references: 8484679
references: Eur J Immunol. 2009 Jan;39(1):216-24
references: 19130584
references: Nat Immunol. 2008 Jun;9(6):650-7
references: 18454150
references: J Exp Med. 2007 Aug 6;204(8):1849-61
references: 17635957
references: Annu Rev Immunol. 2005;23:1-21
references: 15771564
references: Arthritis Rheum. 1996 Jan;39(1):34-40
references: 8546736
references: Arthritis Rheum. 2011 Aug;63(8):2504-15
references: 21381000
references: Ann Rheum Dis. 2008 Sep;67(9):1299-304
references: 18063670